SCHEMBL12724006

SCHEMBL12724006

NCCOC(C(F)(F)F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12292953 0.85
SCHEMBL31442997 0.83 ODC1 (0.39)
SCHEMBL31130653 0.79 DNM1 (0.38)
SCHEMBL21432518 0.75
SCHEMBL793331 0.75
Hydrochloric Acid SCHEMBL1334491 0.73
SCHEMBL16081665 0.73
SCHEMBL1734894 0.72 KIF11 (0.32) KIF11
SCHEMBL1128506 0.71 TSHR (0.35)
SCHEMBL27219456 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243477-A1 FLUORINATED POLY(LACTIC-CO-GLYCOLIC ACID) POLYMERS AND CORRESPONDING NANOPARTICLES AND DRUG ENCAPSULATED NANOPARTICLES SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2019-12-26 WO disclosed
US-20110088594-A1 FLUOROSURFACTANTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-04-21 US disclosed
US-20110088594-A1 FLUOROSURFACTANTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-04-21 US disclosed
WO-2009149807-A1 FLUOROSURFACTANTS MERCK PATENT GMBH (DE) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110088594-A1 FLUOROSURFACTANTS AFF2, AFF1, TERT KIF11 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.